This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-267357-7aap2cte | What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus? |
| cord-267357-7aap2cte | Worth preventing, but how? |
| cord-286132-ag2l1xa7 | Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? |
| cord-286132-ag2l1xa7 | Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-286132-ag2l1xa7 | Immunology taught by human genetics IL-23 is essential for T cell- mediated colitis and promotes inflammation via IL-17 and IL-6 IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune- mediated inflammatory diseases Critical role of IL-17RA in immunopathology of influenza infection What to add to nothing? |
| cord-286132-ag2l1xa7 | Th1/ Th17 response after allogeneic hematopoietic cell transplantation Assessing the quality of reports of randomized clinical trials: is blinding necessary? |
| cord-286132-ag2l1xa7 | The safety of ustekinumab for the treatment of psoriatic arthritis Association of Noninfectious Pneumonia With Ustekinumab Use Editorial: The explosive epidemic outbreak of novel coronavirus disease COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security Should biologics for psoriasis be interrupted in the era of COVID-19? |
| cord-301478-j4b2534p | Should biologics for psoriasis be 97 interrupted in the era of COVID-19? |
| cord-276147-30buoweg | Five staff members of the Dermatology Department were exclusively assigned to assist the admitted patients that Covid Toes: Phenomenon or Epiphenomenon? |
| cord-256565-59bnifxm | COVID-19, syphilis and biologic therapies for psoriasis andpsoriatic arthritis: a word of caution Should biologics for psoriasis be interrupted in the era of COVID-19? |
| cord-262311-vdbk50pl | Does Hydroxychloroquine Combat COVID-19? |
| cord-294871-bqw48zi5 | Compared to what? |
| cord-350317-a9qd3xdr | If skin is a target of SARS- CoV-2, what might be the consequence of using the IL-17 antibody? |
| cord-350317-a9qd3xdr | Should biologics for psoriasis be interrupted in the era of COVID-19? |
| cord-273493-xsroivzj | COVID-19 pneumonia: a random association? |
| cord-309914-1lpl26eo | In particular, is there an increased risk of acquiring the infection or 38 experiencing a worse outcome from SARS- CoV-2? |
| cord-353247-swex393r | ( Program Director? |
| cord-353247-swex393r | Are programs going to be coordinating virtual interview dates? |
| cord-353247-swex393r | Chief resident?) |
| cord-353247-swex393r | How can applicants strengthen their applications( especially those with weaker test scores and those who have had opportunities cancelled)? |
| cord-353247-swex393r | How can international medical students strengthen their applications this year? |
| cord-353247-swex393r | How do I find contact information? |
| cord-353247-swex393r | How should I address"red flags"on my application( e.g., lowStep 1 score, personal leave of absence, repeating clinical rotations)? |
| cord-353247-swex393r | How should I include research experiences and projects that have been delayed or cancelled on my application? |
| cord-353247-swex393r | How should applicants get the best feel for programs now that in- person meet- and- greets, away rotations, and interviews are cancelled? |
| cord-353247-swex393r | How should applicants prepare for virtual interviews? |
| cord-353247-swex393r | How should students express interest in specific programs given most dermatology away rotations are cancelled? |
| cord-353247-swex393r | How should students without a home dermatology program approach away rotations? |
| cord-353247-swex393r | How will different application components be weighted( e.g., letters of recommendation, personal statement, clerkship grades)? |
| cord-353247-swex393r | Is it beneficial to take a year off to do research in dermatology? |
| cord-353247-swex393r | Should I have a region- specific strategy? |
| cord-353247-swex393r | Should I tailor my personal statement to specific programs? |
| cord-353247-swex393r | Should a mentor advocate for me or make calls on my behalf? |
| cord-353247-swex393r | Who should I contact in the department/ division? |
| cord-353247-swex393r | Will virtual rotations accept international medical students? |
| cord-353247-swex393r | test scores weighted differently this year and if so, how? |
| cord-305119-y3a1qyi9 | Should biologics for psoriasis be interrupted in the era of COVID-19? |
| cord-323241-1twnqr4k | A new possible route of infection? |
| cord-323241-1twnqr4k | Therefore, if saliva and feces are both capable of carrying the virus and ACE2 is expressed both in the glandular cells of rectal epithelia and oral mucosa, how can we be sure that sexual intercourse does not represent another way of contagion? |
| cord-323241-1twnqr4k | Transmission routes of 2019-nCoV and controls in dental practice COVID-19: faecal- oral transmission? |
| cord-308212-l8flyso7 | What is the role of patient autonomy in public health emergencies? |
| cord-295371-ccqne6nu | Can I refuse, and even consider litigation? |
| cord-266589-oj76ol8v | COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-266589-oj76ol8v | Should biologics for psoriasis be interrupted in the era of COVID-19? |
| cord-354902-t9df8vhc | Should biologics for psoriasis be interrupted in 54 the era of COVID-19? |
| cord-332859-j10n38ah | What should we do? |
| cord-322798-5r3kf9wa | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-322798-5r3kf9wa | Modernizing clinical practice guidelines for the American Academy of Dermatology Fair Allocation of Scarce Medical Resources in the Time of Covid-19 Should biologics for psoriasis be interrupted in the era of COVID-19? |
| cord-302993-t4quwfva | Are medical students adequately prepared to diagnose and treat common 110 dermatologic conditions in the United States? |